Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Imagenebio, Inc. (IMA) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Imagenebio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1835579.
Total stock buying since 2021: $30,274,662.
Total stock sales since 2021: $797,902.
Total stock option exercises since 2021: $281,887.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 351,167 | $10,499,892 | 0 | $0 | 758 | $0 |
| 2022 | 504,450 | $2,225,970 | 1,000 | $12,000 | 72,786 | $279,741 |
| 2021 | 1,096,800 | $17,548,800 | 53,556 | $785,902 | 1,000 | $2,146 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 351,167 | $10,499,892 | 0 | $0 | 758 | $0 |
| 2022-06 | 504,450 | $2,225,970 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 1,000 | $12,000 | 72,786 | $279,741 |
| 2021-12 | 0 | $0 | 53,556 | $785,902 | 1,000 | $2,146 |
| 2021-03 | 1,096,800 | $17,548,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-25 | Bonita David P | Buy | 83,611 | 29.90 | 2,499,968 |
| 2025-07-25 | Bonita David P | Option Ex | 379 | .00 | 0 |
| 2025-07-25 | Stampacchia Otello | Buy | 267,556 | 29.90 | 7,999,924 |
| 2025-07-25 | Stampacchia Otello | Option Ex | 379 | .00 | 0 |
| 2022-06-24 | Orbimed Genesis Gp Llc | Buy | 162,000 | 4.87 | 788,940 |
| 2022-06-24 | Bonita David P | Buy | 162,000 | 4.87 | 788,940 |
| 2022-06-23 | Orbimed Genesis Gp Llc | Buy | 23,419 | 3.71 | 86,884 |
| 2022-06-23 | Bonita David P | Buy | 23,419 | 3.71 | 86,884 |
| 2022-06-22 | Orbimed Genesis Gp Llc | Buy | 66,806 | 3.55 | 237,161 |
| 2022-06-22 | Bonita David P | Buy | 66,806 | 3.55 | 237,161 |
| 2022-01-18 | Tessier Maude (Chief Business Officer) | Option Ex | 71,786 | 3.87 | 277,596 |
| 2022-01-11 | Zhang Xiaoyan Michelle (Chief Scientific Officer) | Sale | 964 | 12.00 | 11,568 |
| 2022-01-11 | Zhang Xiaoyan Michelle (Chief Scientific Officer) | Option Ex | 964 | 2.15 | 2,068 |
| 2022-01-10 | Zhang Xiaoyan Michelle (Chief Scientific Officer) | Sale | 36 | 12.00 | 432 |
| 2022-01-10 | Zhang Xiaoyan Michelle (Chief Scientific Officer) | Option Ex | 36 | 2.15 | 77 |
| 2021-12-14 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 5,959 | 14.00 | 83,426 |
| 2021-12-14 | Formela Jean Francois (Director) | Sale | 5,959 | 14.00 | 83,426 |
| 2021-12-13 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 8,330 | 14.64 | 121,951 |
| 2021-12-13 | Formela Jean Francois (Director) | Sale | 8,330 | 14.64 | 121,951 |
| 2021-12-10 | Zhang Xiaoyan Michelle (Chief Scientific Officer) | Sale | 1,000 | 14.76 | 14,760 |
| 2021-12-10 | Zhang Xiaoyan Michelle (Chief Scientific Officer) | Option Ex | 1,000 | 2.15 | 2,146 |
| 2021-12-10 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Sale | 11,989 | 15.03 | 180,194 |
| 2021-12-10 | Formela Jean Francois (Director) | Sale | 11,989 | 15.03 | 180,194 |
| 2021-03-30 | Orbimed Genesis Gp Llc (Director) | Buy | 423,400 | 16.00 | 6,774,400 |
| 2021-03-30 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Buy | 125,000 | 16.00 | 2,000,000 |
| 2021-03-30 | Bonita David P (Director) | Buy | 423,400 | 16.00 | 6,774,400 |
| 2021-03-30 | Formela Jean Francois (Director) | Buy | 125,000 | 16.00 | 2,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Imagenebio, Inc. (symbol IMA, CIK number 1835579) see the Securities and Exchange Commission (SEC) website.